“…MRI-guided laser interstitial thermal ablation (MRIgLITT) was initially used as surgical treatment for patients with liver metastases, 1 tumors, and gliomas. 2 Over the past 5 years, Visualase (Medtronic, Englewood, CO, USA) and NeuroBlate systems (formerly AutoLITT, Monteris Medical, Inc, Plymouth, MN, USA), 3 gained acceptance for the treatment of epilepsy, and MRIgLITT became a widely used surgical alternative for mesial temporal lobe (MTL) epilepsy, [3][4][5][6][7][8][9][10] hypothalamic hamartomas, 11 periventricular nodular heterotopia, 12,13 cavernous malformations, 14 and focal cortical dysplasias. 15 The application of MRIgLITT in these cases is particularly appealing as it allows for a targeted lesioning of the putative ictal-onset zone, with little or no collateral damage.…”